Skip to main content
Natco Pharma Ltd. logo

Natco Pharma Ltd. — Investor Relations & Filings

Ticker · NATCOPHARM ISIN · INE987B01026 LEI · 33580086GIBRWXSNGG39 BSE.NS Manufacturing
Open in API
Filings indexed 1,708 across all filing types
Latest filing 2021-02-05 Regulatory Filings
Country IN India
Listing BSE.NS NATCOPHARM

About Natco Pharma Ltd.

https://www.natcopharma.co.in/

Natco Pharma Ltd. is a vertically integrated organization focused on the development, manufacturing, and marketing of complex generics and active pharmaceutical ingredients (APIs). The company specializes in niche therapeutic areas, maintaining a leadership position in oncology and a significant presence in specialty segments such as hepatology, cardiology, and diabetology. Natco is recognized for its expertise in high-barrier-to-entry products, including complex oral solids and injectables. Its business model emphasizes research and development to deliver affordable versions of life-saving medicines globally. With a robust portfolio of finished dosage formulations and a strong supply chain for APIs, the company serves diverse international markets, including North America, Europe, and emerging economies, through strategic partnerships and direct distribution channels.

Recent filings

Filing Released Lang Actions
NATCO receives approval for Chlorantraniliprole (CTPR)- 1st key product of Crop Health Sciences Division
Regulatory Filings
2021-02-05 English
Please further note that pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time TRADING WINDOW for dealing in the securities of the Company ....
Regulatory Filings
2021-02-03 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a notice from the company to stock exchanges about an upcoming Board Meeting scheduled for February 11, 2021. The agenda includes consideration of unaudited financial results for the quarter and nine months ended December 31, 2020, and a possible interim dividend. The document also mentions the closure of the trading window for insiders. The document is short (1822 characters) and serves as an announcement of a future event (Board Meeting) rather than the actual financial results or report. It does not contain financial statements or detailed financial data. Therefore, it is not an Interim Report (IR) or Earnings Release (ER). It is also not a Management Report or Annual Report. The document is a regulatory announcement related to compliance with SEBI regulations and disclosure requirements. Hence, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other categories.
2021-02-03 English
Board Meeting — Financial Results/Dividend
Regulatory Filings Classification · 95% confidence The document is a notice from the company to stock exchanges about an upcoming Board Meeting scheduled for February 11, 2021. The agenda includes consideration of unaudited financial results for the quarter and nine months ended December 31, 2020, and a possible interim dividend. The document also mentions the closure of the trading window for insiders. The document is short (1822 characters) and serves as an announcement of a future event rather than containing actual financial results or detailed reports. It does not contain financial statements or substantive financial data. Therefore, it is not an Interim/Quarterly Report (IR) or Earnings Release (ER). It is a regulatory announcement about a Board Meeting and related disclosures under SEBI regulations. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-02-03 English
NATCO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2021 ,inter alia, to consider and approve the Unaudited Financial Results ....
Regulatory Filings
2021-02-03 English
Allotment of 104695 equity shares of Rs.2/- each to the eligible employees of the company under NATSOP2017 scheme
Regulatory Filings
2021-01-29 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.